MedTrace Logo

PET Imaging to Determine the Role of PET in the Assessment of Regional Disease in Breast Cancer (PET PREDICT Trial)

NCT00201942 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 336

Last updated 2007-10-18

No results posted yet for this study

Summary

The overall goal of this study is to determine how FDG-PET can be incorporated into the assessment of the axilla in the staging and treatment of women with early stage breast cancer.

A multicentre, prospective, diagnostic accuracy study will be conducted evaluating the ability of positronic emission tomography using fluorodeoxyglucose (FDG-PET) to detect the presence or absence of axillary lymph node metastases in newly diagnosed breast cancer patients with no clinical evidence of spread of disease beyond the breast.

Conditions

Interventions

PROCEDURE

PET scan

Sponsors & Collaborators

  • Ontario Ministry of Health and Long Term Care

    collaborator OTHER_GOV

  • Ontario Clinical Oncology Group (OCOG)

    lead OTHER

Principal Investigators

  • Kathleen Pritchard, MD · Sunnybrook Regional Cancer Centre

  • Claire Holloway, MD · Sunnybrook Regional Cancer Centre

  • David McCready, MD · Princess Margaret Hospital, Canada

  • Jim Julian, M.Math. · McMaster University

  • Mark N Levine, MD · Ontario Clinical Oncology Group (OCOG)

  • Wendy Shelley, MD · Kingston Regional Cancer Centre

  • Karen Gulenchyn, MD, PhD · McMaster University

  • Frances O'Malley, MD · MOUNT SINAI HOSPITAL

Study Design

Allocation
NON_RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-02-28
Completion
2007-05-31

Countries

  • Canada

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00201942 on ClinicalTrials.gov